• Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor investor investor investor investor investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*
N/A

$500m

Post IPO Debt
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth40 %1 %(2 %)(3 %)(4 %)4 %6 %
EBITDA0000000000000000000000000000
% EBITDA margin(3 %)11 %6 %17 %26 %27 %29 %
Profit0000000000000000000000000000
% profit margin17 %(96 %)(26 %)(36 %)13 %14 %16 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue26 %29 %30 %27 %---

Source: Company filings or news article, Equity research estimates

More about Illumina
Edit

Apply to Illumina Accelerator by Oct 1, 2022 for our 16th funding cycle in the SF Bay Area & our 6th funding cycle in Cambridge, UK!

Illumina for Startups is focused solely on creating an innovation ecosystem for the genomics industry by partnering with leading venture capital investors and entrepreneurs to create, launch, and grow genomics startups. Illumina for Startups initiatives include Illumina Accelerator, founded in 2014, and Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, founded in 2021.

Illumina Accelerator is a company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has invested in 68 genomics startups from across the globe, which have collectively raised over $1B in venture capital funding.

[email protected]

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit
  • Edit
Bluebee
ACQUISITION by Illumina Jun 2020
GenoLogics
ACQUISITION by Illumina Aug 2015
Verinata Health
ACQUISITION by Illumina Jan 2013
Advanced Liquid Logic
ACQUISITION by Illumina Jul 2013
SomaLogic
ACQUISITION by Illumina Jun 2025
View 87 more